AVEFF (Avecho Biotechnology) Moat Score: 2/10 (As of Jul. 06, 2026)


What is Avecho Biotechnology Moat Score?

Avecho Biotechnology AVEFF -74.14% Moat Score is 2 as of Jul. 06, 2026. The stock has 2 warning signs investors should review. Among 1,395 Biotechnology companies, Avecho Biotechnology ranks better than 58.28% on this metric.

Avecho Biotechnology has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Avecho Biotechnology has No Moat: Avecho Biotechnology operates in a highly competitive biotech sector with limited market share and lacks significant intellectual property or regulatory barriers. The company's innovation and R&D capabilities are not yet proven to provide a sustainable competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Avecho Biotechnology might have No Moat - Very weak/transient advantages.

Avecho Biotechnology  (OTCPK:AVEFF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Avecho Biotechnology Moat Score Related Terms

AVEFF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Avecho Biotechnology's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avecho Biotechnology Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Moat Score distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Avecho Biotechnology (AVEFF) has a Moat Score of 2 as of Jul. 06, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Avecho Biotechnology ranks #582 out of 1395 companies in the Biotechnology industry, placing it in the top 41.7%.
Is Avecho Biotechnology's Moat Score too high?
Avecho Biotechnology's current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Avecho Biotechnology's value of 2 is 0% at this industry median. Based on the distribution chart, Avecho Biotechnology ranks #582 out of 1395 companies in the Biotechnology industry, which is above the industry midpoint.
How does Avecho Biotechnology's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #582 out of 1395 companies for Moat Score. This puts Avecho Biotechnology in the upper half of its industry. The industry median Moat Score is 2.00. Avecho Biotechnology's value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,395 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avecho Biotechnology's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avecho Biotechnology's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current Moat Score is 2 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:GermanyAVE:Australia
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.